These data are being presented in three oral presentations at the ongoing European Alliance of Associations for Rheumatology (EULAR) 2025 Congress, which is being held from June 11-14, 2025, in ...

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress Provided by GlobeNewswire Jun 11, 2025, 3: ...

Schmolik, V., et al. (2025) Health services usage in the Austrian osteoarthritis registry show a high level of non-evidence-based therapies. Presented at EULAR 2025; OP0236-HPR. Ann Rheum Dis 2025 ...

Fewer than one in six guidelines put forth by the ACR and EULAR are backed up by head-to-head, randomized clinical trials, according to data derived from Henry K, et al. ACR Open. 2022;doi:10.1002 ...

News & Views Published: 03 December 2013 Rheumatoid arthritis New EULAR guidelines for RA: a job well done Joel M. Kremer Nature Reviews Rheumatology 10, 6–8 (2014) Cite this article ...

Cabaletta is presenting new clinical and translational data from 18 evaluable patients who were dosed with rese-cel across the RESET-Myositis, RESET-SLE and RESET-SSc trials at the EULAR 2025 ...